RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS

RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS

Bibliografske podrobnosti
Main Authors:	Matthews, D, Aldington, S, Stratton, I, Kohner, E
Format:	Journal article
Izdano:	1995

Podobne knjige/članki

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
od: Stratton, I, et al.
Izdano: (2001)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
od: Kohner, E, et al.
Izdano: (2001)

PROGRESSION OF DIABETIC-RETINOPATHY OVER 6 YEARS IN PATIENTS STUDIED IN THE UK PROSPECTIVE DIABETES STUDY
od: Aldington, S, et al.
Izdano: (1994)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
od: Kohner, E, et al.
Izdano: (1999)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
od: Matthews, DR, et al.
Izdano: (2004)

Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients
od: Stratton, I, et al.
Izdano: (1996)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
od: Aldington, S, et al.
Izdano: (1996)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
od: Stratton, I, et al.
Izdano: (1993)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
od: Matthews, DR, et al.
Izdano: (1998)

PREVALENCE OF RETINOPATHY AT DIAGNOSIS OF TYPE-II DIABETES IN THE UK PROSPECTIVE DIABETES STUDY
od: Kohner, E, et al.
Izdano: (1993)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
od: Matthews, DR, et al.
Izdano: (1998)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY
od: Kohner, E, et al.
Izdano: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN 2964 WHITE CAUCASIAN SUBJECTS AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION
od: Stratton, I, et al.
Izdano: (1995)

Evaluating risk of progression to photocoagulation by retinal photography or direct ophthalmoscopy.
od: Stratton, I, et al.
Izdano: (1997)

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
od: Kohner, E, et al.
Izdano: (1998)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
od: Cull, C, et al.
Izdano: (1999)

Risk factors for presence of hard exudates at diagnosis of Type 2 diabetes and after 6 years.
od: Stratton, J, et al.
Izdano: (2003)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
od: Turner, R, et al.
Izdano: (1991)

Risk factors for neuropathy in UKPDS
od: Stratton, I, et al.
Izdano: (2004)

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.
od: Scanlon, P, et al.
Izdano: (2013)

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
od: Scanlon, P, et al.
Izdano: (2014)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
od: Cull, C, et al.
Izdano: (1995)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
od: Turner, R, et al.
Izdano: (1995)

Epidemiological issues in diabetic retinopathy.
od: Scanlon, P, et al.
Izdano: (2013)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
od: Stevens, R, et al.
Izdano: (2001)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
od: Leal, J, et al.
Izdano: (2021)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
od: Cull, C, et al.
Izdano: (2000)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
od: Turner, R, et al.
Izdano: (1998)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
od: Clarke, P, et al.
Izdano: (2004)

Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?
od: Stratton, I, et al.
Izdano: (2014)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
od: Turner, R, et al.
Izdano: (1998)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
od: Adler, A, et al.
Izdano: (2005)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
od: Wright, A, et al.
Izdano: (2002)

Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes
od: Coleman, R
Izdano: (2016)

Ukpds risk engine
od: Daniel Pinto
Izdano: (2011-01-01)

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.
od: Leal, J, et al.
Izdano: (2013)

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
od: Adler, AI, et al.
Izdano: (2024)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
od: Stevens, R, et al.
Izdano: (2004)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
od: Holman, R, et al.
Izdano: (2001)

A Practical Manual of Diabetic Retinopathy Management
od: Scanlon, P, et al.
Izdano: (2009)